Having this genetic context available during a provider conversation can support a more personalized discussion about energy management, appropriate monitoring, and whether semaglutide or an alternative compounded GLP-1 or GLP-1/GIP combination (like PlexusDx Tirzepatide or GLP-Squared) might better suit your individual physiology
Michael Gibson discuss the FUND-HF trial: Upfront financial support was associated with improved medication adherence but not quality of life compared to delayed support in underserved, low-income patients with HF
The OD and concentration of extracted DNA were detected by SpectraMax QuickDrop (Molecular Devices) and stored at -80 C until analysis
Recientemente, la Sociedad Argentina de Ciruga de la Obesidad (SACO) emiti una declaracin firmada por su presidente, Jorge Harraca, en la que expresa la preocupacin ante mensajes que circulan en redes sociales de profesionales de la salud que, segn su perspectiva, presentan nuevas alternativas teraputicas para la obesidad como soluciones mgicas
No Artificial Additives Free from fillers, GMOs, and unnecessary chemicals
